We have identified in yeast a connection between two master regulators of cell growth: a biochemical connection involving the TORC1 protein kinase (which activates protein synthesis, nutrient uptake, and anabolism) and a biophysical connection involving the plasma membrane proton-pumping H + -ATPase Pma1 (which drives nutrient and K + uptake and regulates pH homeostasis). Raising the temperature to nonpermissive values in a TOR thermosensitive mutant decreases Pma1 activity. Rapamycin, a TORC1 inhibitor, inhibits Pma1 dependent on its receptor Fpr1 and on the protein phosphatase Sit4, a TORC1 effector. Mutation of either Sit4 or Tco89, a nonessential subunit of TORC1, decreases proton efflux, K + uptake, intracellular pH, cell growth, and tolerance to weak organic acids. Tco89 does not affect Pma1 activity but activates K + transport.
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The first mechanisms controlling growth and proliferation of cells probably consisted on direct environmental effects, such as nutrient availability and physicochemical factors such as pH, temperature and water activity. In order to avoid deleterious effects of unfinished cellular activities, a control point named START was introduced at the G1 phase of the cell cycle to ensure that cell growth and division would only start under favorable conditions [1, 2] . Finally, with the development of higher organisms, a second control named 'restriction point', based on hormonal compounds called 'growth factors' was introduced [2] [3] [4] . Tumorigenic transformation of mammalian cells consists on unregulated growth and proliferation and the two control points, START and 'restriction point', are dysregulated in virtually all human cancers [2] . Accordingly, oncogenes are mutated versions of regulatory genes encoding component of signal transduction pathways, including membrane receptors, protein kinases, G proteins, and transcription factors [5] . The TOR protein kinase is an essential regulator of growth in all eukaryotes that is activated by nutrients at START of the cell cycle [6, 7] . It operates through two protein complexes: TORC1 activates energy metabolism, nutrient uptake and synthesis of proteins, nucleotides and lipids while TORC2 regulates actin cytoskeleton and ceramide (sphingolipid) synthesis. TORC1, but not TORC2, is inhibited by the natural drug rapamycin [8, 9] .
In addition to these biochemical systems, cell growth is also regulated by biophysical systems energizing nutrient and K + uptake and extruding protons for pH homeostasis [10] [11] [12] . Cross-talk between both kinds of systems is an important aspect of growth regulation that has been little investigated [12, 13] . In animal cells the Na + /H + exchanger NHE1 is an important proton extrusion system and its activity is regulated by several protein kinases activated by growth factors [14] . The primary pump of these cells, the ouabain-sensitive Na + , K + -ATPase, is essential for cell growth [11, 15] and it drives nutrient uptake and Na + /H + exchange [11] . This ATPase is activated by mitogens [16] but the mechanisms are mostly unknown.
The yeast Saccharomyces cerevisiae is a convenient model system for the study of cell cycle control and cancer [17] , and we have investigated the regulation of its plasma membrane H + -ATPase (Pma1) by the TOR protein kinase. Pma1 is a proton pump essential for cell growth [18] and activated by glucose metabolism [19] . It generates an electrochemical proton gradient that energizes nutrient uptake and regulates extracellular and intracellular pH [20] .
Our results indicate that TORC1 is required for full activity of Pma1 and this regulation is mediated by the protein phosphatase Sit4, a known effector of TORC1. Also, TORC1 subunit Tco89 is needed for activation of K + transport. Therefore, some of the growth-promoting effects of TORC1 may be explained by activation of H + pumping and K + transport resulting in increased nutrient and K + uptake and optimal intracellular pH. This mechanism may also operate in animal cells, where TORC1 could activate their primary pump, the Na 
Materials and methods

Yeast strains and cell culture
Strain SH221 is a thermosensitive TOR mutant (genotype MATa leu2-3,112 trp1 ura3 rme1 his4 HMLa ade2 his3 tor1:: HIS3 tor2::ADE2/YCplac111::tor2-21 ts ) and strain SH100 is the corresponding TOR wild-type control (genotype MATa leu2-3,112 trp1 ura3 rme1 his4 HMLa ade2 his3 tor1::HIS3 tor2::ADE2/YCplac111::TOR2) [21] . Strain BY4741 (genotype MATa his3D1 leu2D0 met15D0 ura3D0) [22] is the wild-type control for the null mutants fpr1D0, sit4D0, and tco89D0 [23] .
Yeast cells were grown overnight in the YPD medium [24] , supplemented with 30 lgÁmL À1 adenine and, unless otherwise indicated, incubated at 28°C corresponding to the early exponential phase (absorbance 0.3-0.4). Cultures were further incubated for 5 h under control or experimental conditions to reach absorbances from 1 to 3 (1.2 to 3.6 9 10 7 cellsÁmL
À1
), corresponding to the late exponential phase. Absorbances were measured with an Ultrospec 10 of Amersham Biosciences (GE Healthcare Life Sciences, Barcelona, Spain) and, when appropriate, cultures were diluted with water to obtain readings below 0.5. One unit absorbance corresponds to 1.1 mg cellsÁmL
. Weight of cells always refers to fresh weight.
Normal YPD medium has a pH of 5.8-6.2 depending on autoclaving time. YPD medium at pH 4.1 was made by the addition (after autoclaving) of 1/10 vol of 0.5 M succinic acid-Tris base pH 3.7 buffer.
Growth curves of different strains at 28°C were made with a Bioscreen C (Thermo Fisher Scientific, Madrid, Spain), an instrument that allows the continuous recording of cell growth [25] . Saturated cultures of different strains were grown for 16-24 h to an absorbance of about 7 and used to inoculate the wells of the instrument to an initial absorbance of 0.03. Absorbance was measured at 600 nm.
Preparation of a membrane fraction enriched in plasma membranes and determination of Pma1 activity
We have determined the activity of Pma1 in membranes isolated from growing yeast cells because glucose in the medium is a major activator of the enzyme and removal of medium results in rapid inactivation [19] . Cells were grown to late exponential phase with 50 mL YPD medium in a 250-mL flask and concentrated by centrifugation (5 min at 800 g in a Nahita 2655 centrifuge) and resuspension in 2 mL of supernatant. After 5 min of incubation at growth temperature for recovery of the physiological state [19] , cells were supplemented with 5 mL of glass beads of 0.5 mm precooled at À20°C (BioSpec Products, Bartlesville, OK, USA) and 400 lL of concentrated extraction buffer (0.3 M Tris-HCl pH 8.0, 0.3 M KCl, and 30 mM EDTA) containing 2 lL 0.5 M dithiothreitol and 80 lL concentrated (25-fold) protease inhibitors cocktail (Roche Applied Science, Penzberg, Germany). Homogenization was effected by shaking in a vortex at top speed during 3 min. Liquid was recovered with a pipette and centrifuged during 5 min at 3000 rev/min and 4°C (Eppendorf, Madrid, Spain, R5415 R centrifuge) to remove debris. Supernatant was further centrifuged during 20 min at 15 700 g and 4°C to obtain membranes. Pellet was resuspended with a Dounce homogenizer (Fisher Scientific, Madrid, Spain) in 100 lL glycerol buffer (20% glycerol, 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 1 mM dithiothreitol), diluted with 900 lL of cold water and centrifuged 30 min at 13000 rev/min and 4°C to remove inorganic phosphate and other contaminants. The pellet was finally homogenized with 200 lL of glycerol buffer and kept frozen.
Measurement of protein concentration and assay of plasma membrane ATPase (Pma1) activity have been described [26] but reactions were made in microtiter wells. The ATPase assay buffer contains inhibitors of mitochondrial ATPase (azide), vacuolar ATPase (nitrate), and acid phosphatase (molybdate). Two determinations were made for every membrane sample, without and with 0.1 mM orthovanadate, a Pma1 inhibitor. Pma1 activity corresponded to ATP hydrolysis resistant to azide, nitrate, and molybdate, and sensitive to vanadate and it represented more than 90% of total ATP hydrolytic activity. Specific activities are given in nmoles PiÁmin
À1
Álg protein À1 .
Measurement of glucose-dependent acidification and rubidium transport
Wild-type yeast (strain BY4741) and sit4D and tco89D mutants were grown in 20 mL of the YPD medium (100 mL flask) corresponding to the late exponential phase (absorbances 1-3). Then, cells were centrifuged 5 min at 3000 rev/min, resuspended in 20 mL water, and incubated for 2 h at 28°C to induce K + efflux and H + influx and activate in this way glucose-induced acidification and K + uptake [27] .
After centrifugation cells were resuspended in 1 mL of water.
The assay for acidification of external medium was made in 2 mL of 10 mM of glycylglycine (pH 4.0) and 100 mM of KCl as described [27] . Reaction was started with 50 lL 20% glucose, calibration was made with pulses of 10 lL 10 mM HCl and pH was recorded with a GLP22 pH meter (Crison, Barcelona, Spain). Results are expressed as nmoles H
Potassium transport was measured by the uptake of its analog rubidium, which shares transporters with K + [28] .
Cells were prepared as described above for the assay of external acidification but incubated at 20 mgÁmL À1 in a medium containing 2% glucose and 50 mM 2-(N-morpholino)ethanesulfonic acid-Tris pH 6.0. After 5 min at 24°C, RbCl was added to a final concentration of 5 mM and samples of 0.5 mL were taken at 0, 10, and 20 min of incubation with shaking at 24°C. After dilution with 10 mL cold 10 mM MgCl 2 cells were centrifuged 5 min at 3000 rev/min, resuspended with 10 mL cold 10 mM MgCl 2 and centrifuged again. Finally, cells were extracted during 5 min at 95°C with 200 lL 10 mM MgCl 2 , centrifuged and diluted in water for assay with an atomic absorption spectrophotometer (SENSAA of GBC Scientific Equipment) working in emission mode.
Determination of intracellular pH and potassium in yeast cells
Intracellular pH (pHi) was measured by the distribution of 14 C-propionic acid inside and outside cells [10, 29] . Wild-type yeast (strain BY4741) and sit4D and tco89D mutants were grown in 15 mL of YPD medium pH 4.1 (100 mL flask) to late exponential phase. Cells were centrifuged (5 min at 3000 rev/min) and resuspended with 3 mL of supernatant. Then, 3 lL 14 C-propionic acid (100 lCiÁmL À1 and 50-60 CiÁmol À1 ; American Radiolabeled Chemicals, St. Louis, MO, USA) were added and incubated for 10 min to equilibrate with the pH gradient. Samples of 0.5 mL were taken, diluted with 10 mL of cold washing solution (20 mM KCl and 1 mM MgCl 2 ), filtered on glass fiber disks (Whatman GF/C) and washed on the filter with 10 mL of cold washing solution. Filters were dried at room temperature for 30 min and radioactivity determined by liquid scintillation counting. Washing controls were made with cells treated for 10 min at 95°C before incubation with 14 C-propionic acid and had radioactivity values 5-10% of experimental samples.
For the determination of intracellular K + cells were grown to late exponential phase in YPD medium and cells from 5 mL culture were centrifuged 5 min at 3000 rev/min, resuspended with 5 mL cold 10 mM MgCl 2 and centrifuged again to remove external K + . This washing step was repeated and finally cells were extracted during 5 min at 95°C with 500 lL of 10 mM MgCl 2 . After centrifugation as stated earlier, the supernatant was diluted in water for assay with an atomic absorption spectrophotometer (SEN-SAA of GBC Scientific Equipment) working in emission mode.
Western blot analysis of Pma1
Polyacrylamide gel electrophoresis (8% resolving gel) with sodium dodecylsulfate [30] and transfer of proteins from gel to PVDF membrane [31] were as described. Samples for electroforesis could not be prepared by the usual procedure of boiling the sample in SDS because this aggregates Pma1. As incubation with SDS at low temperature triggers proteolysis by endogenous proteases, samples were first precipitated with 5% trichloroacetic acid, washed with cold water, and resuspended with Laemmli sample buffer at 37°C. Size standard was the PageRuler prestained Protein Ladder (Thermo Scientific, Waltham, MA, USA) and the apparent molecular weights of these bands were slightly lower than theoretical. Quantitation of Pma1 by western blotting was made with a rabbit polyclonal antibody against purified Pma1 [18] . The activation state of Pma1 was investigated with an antibody against the phosphorylated peptide corresponding to amino acids 904-917 of Pma1 and containing phosphoserine and phosphothreonine at positions 911 and 912, respectively [32] . Detection of the labeled blots was done using an Amersham ECL system (GE Healthcare Life Sciences) and quantitation was done with the Java-based image-processing program IMAGEJ (http://rsb.info.nih.gov/ij/ ). Blots were first decorated with the antibody against the phosphorylated peptide described above, stripped by incubation for 1 h in 0.2 M glycine/HCl (pH 2.7), decorated with antibody against Pma1, and finally stained for total protein with Direct Blue 71.
Results
TOR is required for full activity of Pma1
The TOR is an essential protein and a null mutant is nonviable. Therefore, we have utilized a thermosensitive mutant generated in the laboratory of Michael N. Hall (Basel) by the following strategy [21] . In yeast there are two TOR genes, TOR1 and TOR2, the Tor2 protein can form part of the two TOR complexes (TORC1 and TORC2) but Tor1 only participates in TORC1. Accordingly, TOR2 is an essential gene bur TOR1 is not. Strain SH221 contains a null mutation in TOR1 and a thermosensitive mutation in TOR2 while the control or wild-type strain (SH100) contains a null mutation in TOR1 but a wild-type TOR2 gene. As indicated in Fig. 1A , at 25°C the thermosensitive strain grows slightly less than the control strain and reach the same final absorbance. At 37°C, however, the thermosensitive strain experiences a considerable decrease in growth and reach much lower absorbance than the control strain, that grows normally at this temperature.
As indicated in Fig. 1B , in the control strain, the activity of Pma1 from cells grown at 37°C is 95% of that from cells grown at 25°C and the difference is not statistically significant. On the other hand, in the thermosensitive mutant, the activity of Pma1 from cells grown at 37°C is 53% of that from cells grown at 25°C and the difference is statistically significant. Therefore, thermal inactivation of TOR decreases Pma1 activity by about half.
TORC1 regulates Pma1
The TOR mutant utilized for the above experiments (tor1 tor2-21; class C mutant [21] ) is thermosensitive for both TOR complexes (TORC1 and TORC2) and therefore we have tested the effect on Pma1 activity of rapamycin, a specific inhibitor of TORC1 [7, 8] . In order to control for nonspecific effects of the drug we used a mutant (fpr1D) devoid of the rapamycin receptor and therefore resistant to specific effects of the drug [33, 34] . As indicated in Fig. 2A rapamycin at 0.1 lM strongly inhibits growth in the wild-type strain but no inhibition is observed in the fpr1D mutant. Rapamycin has no effect on the Pma1 activity of the fpr1D mutant but it reduces the activity of wild-type to 57% of control cells (Fig. 2B) , an inhibition similar to the one observed with the thermosensitive TOR mutant at nonpermissive temperature (see above). The same inhibition was obtained with 0.1 and 0.5 lM rapamycin (data not shown), indicating that the partial nature of the effect was not due to insufficient concentration of the inhibitor. These results indicate that TORC1 is the TOR complex required for maximum activity of Pma1.
Sit4 mediates the effect of TORC1 on Pma1
Pma1 is a very abundant protein located at the plasma membrane [35] and its activation by TORC1 probably requires intermediate regulatory proteins because of the low abundance and poor mobility of the TOR regulatory complex [7] [8] [9] . The best-known proximal effectors of TORC1 are protein kinase Sch9, protein phosphatases 2A Pph21, Ppg1 and Sit4 and Tap42, a regulatory protein interacting with these phosphatases [7] [8] [9] . TAP42 is an essential gene [23, 36] and the phenotypes of null mutants of the other effectors indicate that sch9D [37] , pph21D [38] , and ppg1D [39] are acid tolerant while sit4D is acid sensitive [40] . A mutant with reduced activity of Pma1 should be acid sensitive [10, 29] and, accordingly, Pma1 activity in isolated membranes of the sit4D mutant is 55% of wild-type (Fig. 3A) . The rate of in vitro ATP hydrolysis of several Pma1 mutants has been shown to correlate with the rate of acidification of glucose metabolizing cells [41] and as indicated in Fig. 3B , the cells of the sit4D mutant have reduced proton extrusion activity (47% of wild-type).
The Pma1 activity of sit4D is insensitive to rapamycin (Fig. 4B) , suggesting that Sit4 mediates the effect of TORC1 on Pma1. Growth of sit4D cells is inhibited by rapamycin (Fig. 4A ) because TORC1 has many important growth-promoting activities in addition to activate Pma1 [6, 7] .
Tco89, a TORC1 subunit, regulates proton efflux from cells by activating K + transport
The catalytic subunit of protein kinase TORC1 is encoded in yeast by two partially redundant genes, TOR1 and TOR2. This subunit is essential because the double null mutant tor1 tor2 is not viable [7, 21] . Tco89 is the only nonessential subunit of TORC1 [7] and our results indicate that its null mutation (tco89D) has no significant effect on Pma1 activity of isolated membranes (Fig. 3A) . Surprisingly, this mutant exhibits a reduced acidification rate by cells, similar to that of sit4D mutant (Fig. 3B ). H + efflux from cells depends not only on proton pumping by Pma1 but also on electrical balance by cation uptake and anion efflux. In yeast the major contribution for this balance corresponds to K + transport [42, 43] and therefore we have investigated if Tco89 affects this system.
The results of Table 1 indicate that the rate of rubidium uptake (utilized as a tracer of K + uptake [28] ) in the sit4D and tco89D mutants is 51 and 53% of wild-type, respectively. As indicated in the same table, this reduction in uptake rate correlates with a decrease in the steady-state level of intracellular K + in growing cells, which in the sit4D and tco89D mutants is 61 and 65% of wild-type, respectively. We can interpret these results with a model where Sit4 activates Pma1, the proton pump, by increasing its enzymatic activity and this results in hyperpolarization that increases K + uptake. On the other hand, Tco89 does not increase the enzymatic activity of Pma1 but activates K + transporters and this results in depolarization that increases proton efflux.
Intracellular pH of sit4D and tco89D mutants is more acidic than in wild-type
The intracellular pH of sit4D and tco89D mutants should be more acidic than in wild-type because of their reduced capability for proton efflux (Fig. 3B) . This was confirmed in Fig. 5 . For wild-type cells growing at pH 4.1 pHi was 6.42, similar to previously described [10] , and addition of acetic acid reduced this value to 6.20. The pHi of growing cells of sit4D and tco89D mutants was 6.25 and 6.27, respectively, and decreased to 6.05 and 6.03 in the presence of acetic acid. 
Growth of sit4D and tco89D mutants is sensitive to weak organic acids
The decrease in H + efflux, K + transport, and pHi of sit4D and tco89D mutants described above suggest that growth of these strains should be slower than wild-type [10] and more sensitive to weak organic acids that diffuse into cells to lower pHi [40] . Actually, both mutants are known to have reduced growth [44] and our results provide a mechanism for this observation based on pHi and K + homeostasis. Concerning organic acids, sit4D has been described to be sensitive to sorbic acid [40] but there is no information about tco89D. Growth experiments were performed in a system (Bioscreen C) that continuously register growth and allows the calculation of growth parameters (lag, growth rate, yield) with greater accuracy than previous methods. . All experiments have been repeated three times (three biological repetitions) and error bars correspond to standard errors. As indicated in Fig. 6A and Table S1 , in normal growth medium sit4D and tco89D have increased lag (2.5 h in both mutants versus 1.5 h in wild-type) and decreased growth rate (70 and 86% of wild-type, respectively). Both mutants are more sensitive to sorbic and acetic acids than wild-type (Fig. 6B,C) , with a greater increase in lag and a greater reduction in growth rate. Growth parameters in the presence of acids were referred to the values for the same strain without acids (Table S1 ). Sorbic and acetic acids decrease growth rate in the control strain by 30 and 45% and in the sit4D mutant by 50 and 55%, respectively. Concerning the lag, sorbic and acetic acids increase it 1.8-fold in wild-type but 2.4-and 4.6-fold, respectively, in sit4D. tco89D was more acid-sensitive than sit4D despite having less growth defect in normal medium. For example, sorbic and acetic acids decrease growth rate by 70% and 80%, respectively.
Discussion
Our results indicate that growth regulation by TORC1 includes basic mechanisms of pH and K + homeostasis. Cell growth requires high intracellular pH and K + [10] [11] [12] and the activation of H + extrusion and K + uptake by TORC1 described in the present work is an important function of TORC1, mediated by Sit4 and Tco89, respectively. Sit4 is a proximal TORC1 effector and Tco89 a subunit of the complex [7] . Sit4 belongs to a group of type 2A protein phosphatases inhibited by TORC1 [7] [8] [9] by promoting binding to them of the inhibitory subunit Tap42 [36, 45] . Sit4 dephosphorylates and activates protein kinase Npr1 and transcription factor Gln3, both involved in scavenging secondary nitrogen sources Table S1 . [46, 47] . However, a mechanism where TORC1 inhibits Sit4 and this activates Pma1 is not supported by our results. If this were the case, the sit4D mutant should have high Pma1 activity and we found the contrary: this mutant has low Pma1 activity insensitive to rapamycin, as if Sit4 were an activator of Pma1 mediating the positive effect of TORC1 on this proton pump. A plausible mechanism would be that, in the context of the proton pump, TORC1 activates Sit4 and this phosphatase, directly or indirectly, activates Pma1. Another situation where TORC1 probably activates Sit4 is during progression through the G1 phase of the cell cycle because, as in the case of Pma1 activation described in the present work, both TORC1 [48] and Sit4 [49] act as positive regulators.
Glucose metabolism is the major factor activating Pma1 [19] and the mechanism involves, as the most important modification, a double phosphorylation of the enzyme at Ser911 and Thr912 by some unknown mechanism [32, 50] . As indicated at Fig. S1 , neither rapamycin nor the sit4D mutation decrease this important phosphorylation (and do not affect the amount of Pma1). Other phosphorylations affecting Pma1 activity to a lower extent occur at Ser899 [32] and Ser507 [51] . Phosphorylation of Ser899 increases the affinity of Pma1 for ATP [32] but, as indicated in Fig. S2 , this affinity is not affected by the sit4D mutation. With respect to Ser507, the S507A mutation has been reported to have no effect on Pma1 activity [51] and this phosphorylation was not further investigated. As a conclusion, the turnover of Pma1, but not its affinity for ATP, is increased by TORC1 and Sit4. The mechanism is elusive because it does not involve the known phosphorylation sites of the enzyme. It has recently been described that rapamycin decreases K + accumulation in yeast cells independently of the Trk1 and Trk2 high-affinity transporters [52] . Our results suggest that this effect could be mediated by the inhibition of Pma1 by rapamycin. The resulting membrane depolarization would result in decreased K + uptake mediated by an uncharacterized low-affinity transporter [53] . In addition, our finding that TORC1 subunit Tco89 is required for the activation of K + transport without affecting Pma1, suggest that TORC1 also affects K + homeostasis in a direct way. One important aspect of these findings is that there is a reciprocal regulation between TORC1 and the H + and K + transport systems. This was first described for the TORC1-K + pair, where a decrease in K + accumulation activates TORC1 and inactivation of TORC1 decreases K + accumulation [52] . In the case of H + pumping it has been described that activation of Pma1 by glucose increases TORC1 activity and that this effect is mediated by an increase in intracellular pH [54] . Our results show the reciprocal effect, TORC1 regulates Pma1. As a final consideration, it must be indicated that the activation of proton pumping and K + uptake by TORC1 is an important mechanism of growth promotion by this master regulator and this adds a novel perspective to the central problem of growth control. For example, we predict that this regulation of the proton pump by TORC1 would be general in organisms with a chemiosmotic circuit of protons (such as fungi and plants), and that in animal cells, with a chemiosmotic circuit of sodium, TORC1 will regulate the sodium potassium pumping ATPase.
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